Although discount cards may help ease the load of higher drug prices during the short term, they do not handle the systemic challenges driving up prescription rates inside the U.S. Broader coverage changes could tackle the foundation triggers of growing drug selling prices, like not enough transparency in pricing plus the position of intermediaries